Flower

Lupin and Lilly partner to improve access to diabetes treatment

by The Welthi Bureau |

lupin and lilly partner to improve access to diabetes treatment
 Image used for representational purpose only

Mumbai, October 1, 2018: Pharma Major Lupin Limited ("Lupin") and Eli Lilly and Company (India) Pvt. Ltd. ("Lilly India"), have announced the expansion of their business partnership aimed at widening access to innovative diabetes medicines in India. Under the new partnership, Lupin will distribute and market Lilly's Aplevant® (dulaglutide), a once-weekly injection for type 2 diabetes treatment.

 

Aplevant® (dulaglutide) is a once-weekly injectable solution for adults with type 2 diabetes mellitus. Lupin expects to make Aplevant® available in India in October 2018.

 

This announcement builds on the Lupin and Lilly India business partnership initiated in 2011 to expand the promotion and distribution of Lilly's diabetes portfolio in India where Lupin has a large network.

 

Rajeev Sibal, President – India Region Formulations, Lupin said, "Our long-standing partnership with Lilly has enabled us to emerge as a strong contender in the diabetes treatment arena. Lupin is the fastest growing company in the Indian diabetes market and is now ranked as the third largest company in the Anti-diabetes market in India on a MATbasis as of August 2018*. With this new partnership, we are expanding our diabetes portfolio to include a once-weekly diabetes treatment, and improving access to innovative medications for better diabetic care in India. We are delighted to partner with Lilly India and hope to continue building our product pipeline through strategic tie-ups for innovative healthcare solutions for patients and healthcare practitioners in India."

 

Luca Visini, Managing Director, Lilly India said, "Lilly's heritage in diabetes spans from the first commercial release of insulin in 1923 to leading scientific discoveries of today. Since 1923, we have continuously strived to innovate to meet the diverse needs of people living with diabetes offering a wide portfolio of treatments among which include the first biosynthetic 'human' insulin with recombinant DNA technology, the first rapid insulin analog, and a once weekly non-insulin injection for type 2 diabetes. Building on this strong heritage and legacy in the diabetes field, and our commitment to making life better for all those living with diabetes in India, we are thrilled to work with Lupin to make our innovative therapies and solutions available to a large number of healthcare professionals and patients who need them."


 Disclaimer: Welthi.com does not guarantee any specific results as a result of the procedures mentioned here, and the results may vary from person to person. Read more
Cochlear Implants to Aid Children With Hearing Difficulties - Surgery to help in improving speech and language skills among the young  Hyderabad, 14th October 2018: Hearing is a one of the most important sense that also plays a very crucial role in verbal

Cochlear Implants to Aid Children With Hearing ...

Surgery to help in improving speech and language s...
“Maxi-O Lipi Flow” world’s best device for dry eyes treatment launched in MaxiVision Eye Hospitals

“Maxi-O Lipi Flow” world’s best device for ...

Now freedom from dry eyes is just a step away in H...
Different bodies, one message

Different bodies, one message

Aishwarya Sharma, a fashion activist and founder a...
Pediatric Liver transplant in Gleneagles Global Hospitals

Pediatric Liver transplant in Gleneagles Global ...

The Gleneagles Global Hospitals Hyderabad is delig...
Child Obesity: A burgeoning barrier to healthy living

Child Obesity: A burgeoning barrier to healthy ...

The World Obesity Day is celebrated on 11th Octobe...
Get off your smart gadgets

Get off your smart gadgets

The repetitive motions of texting and typing can l...
Hyderabad Doctors successfully perform Asia's First Transcatheter Tricuspid Valve Replacement procedure

Hyderabad Doctors successfully perform Asia's ...

Only 40 such surgeries reported around the world...
SuVitas Launches Bangalore’s First Dedicated Transition Care Facility

SuVitas Launches Bangalore’s First Dedicated ...

Catering to a need for post critical care that has...
Itermittent Fasting: The How s and Why's

Itermittent Fasting: The How s and Why's

Intermittent Fasting is the latest global fitness ...
Our responsibility to our emotions

Our responsibility to our emotions

In this world, there are all kinds of people. Some...
Stop drowsing while driving

Stop drowsing while driving

A long spell of work or drive can lead to physical...
Eyes show you the world

Eyes show you the world

With increasing rate of air pollution, the ways it...